Adtalem Global Education Inc. (NYSE:ATGE) Q1 2023 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Chandrika Nigam - Senior Director of Investor Relations Steve Beard - President & Chief Executive Officer Bob Phelan - Senior Vice President & Chief Financial Officer Conference Call Participants Steven Pawlak - Baird Operator Greetings and welcome to the First Quarter Fiscal Year 2023 Earnings Call for Adtalem Global Education. At this time, all participants are in a listen-only mode ...

Adtalem Global Education, Inc. (NYSE:ATGE) Q4 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Chandrika Nigam - Director, IR Stephen Beard - President, CEO & Director Robert Phelan - SVP & CFO Conference Call Participants Jeffrey Meuler - Robert W. Baird & Co. Jeffrey Silber - BMO Capital Markets Operator Greetings. Welcome to the Fourth Quarter Fiscal Year 2022 Earnings Call for Adtalem Global Education. [Operator Instructions]. Please note, this conference is being recorded. ...

Adtalem Global Education Inc. (NYSE:ATGE) Q3 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Chandrika Nigam – Senior Director-Investor Relations Steve Beard – President and Chief Executive Officer Bob Phelan – Senior Vice President and Chief Financial Officer Conference Call Participants Jeff Meuler – Baird Operator Greetings. Welcome to the Third Quarter Fiscal Year 2022 Earnings Call for Adtalem Global Education. [Operator Instructions] Please note, this conference is being reco ...

Financial Data and Key Metrics Changes - Revenue increased by 6.4% to $283.1 million, and diluted earnings per share from continuing operations grew by 35.1% to $0.77 [29][32] - Operating income excluding special items increased by 24.4% to $52.6 million, driven by increased revenue and efficiency [31][32] - Net income from continuing operations excluding special items was $40.5 million, compared to $30.9 million in the prior year [32] Business Line Data and Key Metrics Changes - Medical and Healthcare revenue increased by 6.5% to $234.4 million, primarily driven by Chamberlain's strong enrollment [32][34] - Chamberlain's revenue increased by 13.2%, with new and total student enrollment rising by 8.1% and 10.2% respectively [33] - Financial Services segment revenue grew by 5.9% to $48.7 million, driven by OnCourse Learning and Becker [34] Market Data and Key Metrics Changes - The demand for healthcare professionals remains strong, with Adtalem institutions contributing to vaccine distribution efforts [8][9] - The U.S. nursing education market is valued at $28 billion and is expected to grow at a 21% CAGR to $60 billion by 2024 [11] - The average cohort default rate for Adtalem's institutions is significantly lower than the national average, indicating strong student outcomes [26] Company Strategy and Development Direction - The company aims to increase the talent supply for healthcare professionals and address workforce shortages exacerbated by the pandemic [9][10] - The planned acquisition of Walden University is expected to enhance online capabilities and healthcare offerings, with 77% of Walden's revenue coming from healthcare-related programs [10][12] - Adtalem is focused on operational efficiency and streamlining its portfolio to enhance shareholder value [27][28] Management's Comments on Operating Environment and Future Outlook - Management raised full-year earnings guidance due to strong operational execution and enrollment trends [8][38] - The company anticipates modest COVID-19 related headwinds impacting revenue and expenses in the near term, but expects to overcome these challenges [39] - Long-term growth is expected to align with mid-single-digit revenue growth and low double-digit earnings growth targets [40] Other Important Information - The company has generated $211 million of free cash flow on a trailing 12-month basis, with expectations for significant growth in the coming years [37] - Adtalem is committed to increasing diversity and access in medicine through partnerships with HBCUs and HSIs [20] Q&A Session Summary Question: What are the specific COVID-19 headwinds impacting revenue? - Management noted moderate headwinds related to clinical supply and increased costs for campus safety measures [44] Question: Can you provide quality metrics for Walden similar to those for Chamberlain? - Management highlighted Walden's cohort default rate of around 6.8%, which is competitive compared to peers, and emphasized the need for improvement in employer partnerships [46][47] Question: What is the status of the DOJ inquiry regarding Walden? - Management stated that they have not found evidence supporting the allegations and are conducting a thorough investigation [55]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |-----------------------------------------------------------------------------|-------------------------------------------------| | For the transition | ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 or ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission file number: 001-13988 Adtalem Global Education Inc. Common stock, $0.01 par value per share ATGE New York Stock Exchange NY ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (Mark One) FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |-------------------------------------------------------------------------------|-------------------------------------------------| | For the transition peri ...